歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01672 歌礼制药-B

交易中 08-26 11:33:14

0.790

+0.010

+1.28%

最高0.810	最低0.780	成交量23.80万
今开0.790	昨收0.780	日振幅3.85%
总市值7.96亿	流通市值7.96亿	总股本10.08亿
成交额18.77万	换手率0.02%	流通股本10.08亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"歌礼制药-B","latestPrice":0.79,"timestamp":1724643131484,"preClose":0.78,"halted":0,"volume":238000,"delay":0,"floatShares":1007639000,"shares":1007639000,"eps":-0.14749266,"marketStatus":"交易中","marketStatusCode":2,"change":0.01,"latestTime":"08-26 11:33:14","open":0.79,"high":0.81,"low":0.78,"amount":187680,"amplitude":0.038462,"askPrice":0.8,"askSize":106000,"bidPrice":0.79,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.1474926677007498,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1724644800000},"adr":0,"listingDate":1533052800000,"adjPreClose":0.78,"openAndCloseTimeList":[[1724635800000,1724644800000],[1724648400000,1724659200000]],"volumeRatio":0.570722,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01672/tweets","defaultTab":"tweets","newsList":[{"id":"2461258982","title":"歌礼制药－Ｂ(01672)股价下跌6.173%，现价港币$0.76","url":"https://stock-news.laohu8.com/highlight/detail?id=2461258982","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461258982?lang=zh_cn&edition=full","pubTime":"2024-08-23 10:52","pubTimestamp":1724381520,"startTime":"0","endTime":"0","summary":"[下跌股]歌礼制药－Ｂ(01672) 股价在上午10:52比前收市价下跌6.173%，现股价为港币$0.76。至目前为止，今日最高价为$0.81，而最低价为$0.76。总成交量为37.4万股，总成交金额为港币$29.16万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240823747/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","01672","BK1574","01477","BK1191","BK1161"],"gpt_icon":0},{"id":"2460702517","title":"歌礼制药-B08月19日遭主力抛售86万元 环比增加352.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460702517","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460702517?lang=zh_cn&edition=full","pubTime":"2024-08-19 16:15","pubTimestamp":1724055318,"startTime":"0","endTime":"0","summary":"08月19日, 歌礼制药-B股价跌3.61%，报收0.80元，成交金额197万元，换手率0.24%，振幅6.02%，量比3.03。歌礼制药-B今日主力资金净流出86万元，连续3日净流出，上一交易日主力净流出19万元，今日环比增加352.63%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为60.00%，平均跌幅为2.72%。该股近5个交易日下跌5.88%，主力资金累计净流出120万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出573万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408191615299f390c55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408191615299f390c55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","01672","BK1574","01477","BK1191"],"gpt_icon":0},{"id":"2458530195","title":"歌礼制药-B08月09日主力资金流出27万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2458530195","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458530195?lang=zh_cn&edition=full","pubTime":"2024-08-09 16:16","pubTimestamp":1723191417,"startTime":"0","endTime":"0","summary":"08月09日, 歌礼制药-B股价跌2.22%，报收0.88元，成交金额164万元，换手率0.19%，振幅6.67%，量比1.81。歌礼制药-B今日主力资金净流出27万元，连续3日净流出，上一交易日主力净流出43万元，今日环比减少37.21%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为60.00%，平均跌幅为2.72%。该股近5个交易日下跌18.87%，主力资金累计净流出93万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出320万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809161755958b3eda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809161755958b3eda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","BK1191","BK1574","01477","01672"],"gpt_icon":0},{"id":"2458048243","title":"歌礼制药-B盘中异动 早盘股价大跌5.56%报0.850港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458048243","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458048243?lang=zh_cn&edition=full","pubTime":"2024-08-09 09:35","pubTimestamp":1723167323,"startTime":"0","endTime":"0","summary":"2024年08月09日早盘09时35分，歌礼制药-B股票出现波动，股价急速下跌5.56%。截至发稿，该股报0.850港元/股，成交量17.8万股，换手率0.02%，振幅3.33%。资金方面，该股资金流入0港元，流出15.502万港元。歌礼制药-B股票所在的生物技术行业中，整体涨幅为0.29%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080909352496825452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080909352496825452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1563","01672","BK1191","01477","BK1574","BK1594","03323","BK1503","BK1515","BK1589","BK1135"],"gpt_icon":0},{"id":"2457788363","title":"歌礼制药-B08月08日遭主力抛售43万元 环比增加230.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457788363","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457788363?lang=zh_cn&edition=full","pubTime":"2024-08-08 16:16","pubTimestamp":1723105005,"startTime":"0","endTime":"0","summary":"08月08日, 歌礼制药-B股价跌10.00%，报收0.90元，成交金额207万元，换手率0.23%，振幅8.00%，量比3.56。歌礼制药-B今日主力资金净流出43万元，上一交易日主力净流出13万元，今日环比增加230.77%。该股近5个交易日下跌17.43%，主力资金累计净流出66万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出303万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408081617389f19cf10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408081617389f19cf10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","01477","BK1574","01672","BK1191"],"gpt_icon":0},{"id":"2457559453","title":"港股异动 | 歌礼制药-B(01672)重挫11% 上半年大幅预亏超1.27亿元 利托那韦产品无贡献销售收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2457559453","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457559453?lang=zh_cn&edition=full","pubTime":"2024-08-08 14:15","pubTimestamp":1723097700,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，歌礼制药-B(01672)跌11%，截至发稿，跌11%，报0.89港元，成交额146.89万港元。消息面上，歌礼制药发盈警，预期截至2024年6月30日止六个月取得公司权益拥有人应占净亏损介于人民币1.273亿元至1.323亿元，去年同期净亏损为1660万元。公告指，亏损大幅增加主要因内地的新冠肺炎疫情得到有效控制，令市场对利托那韦产品的需求收缩，因此上半年并无取得利托那韦产品销售收入，且研发成本有所增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1161501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","01672","BK1574","01477","BK1191","BK1161"],"gpt_icon":0},{"id":"2457956353","title":"歌礼制药-B(01672)下跌10.0%，报0.9元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2457956353","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457956353?lang=zh_cn&edition=full","pubTime":"2024-08-08 14:01","pubTimestamp":1723096861,"startTime":"0","endTime":"0","summary":"8月8日，歌礼制药-B盘中下跌10.0%，截至14:01，报0.9元/股，成交123.2万元。该公司在浙江绍兴滨海新城拥有约17,000平方米的生产基地，设计年产能为1.3亿片，拥有多款在研药物并已取得药品生产许可证。截至2023年年报，歌礼制药-B营业总收入5659.6万元、净利润-1.45亿元。8月7日，预计2024年中报业绩预减，归属股东应占溢利约-1.323亿人民币至-1.273亿人民币，同比下降666.87%至696.99%。8月30日，歌礼制药-B将披露2024财年中报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/08140142169070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01672","01477","BK1191","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"2457353955","title":"歌礼制药-B(01672)下跌9.0%，报0.91元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2457353955","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457353955?lang=zh_cn&edition=full","pubTime":"2024-08-08 13:59","pubTimestamp":1723096741,"startTime":"0","endTime":"0","summary":"8月8日，歌礼制药-B盘中下跌9.0%，截至13:59，报0.91元/股，成交103.19万元。该公司在浙江绍兴滨海新城拥有约17,000平方米的生产基地，设计年产能为1.3亿片，拥有多款在研药物并已取得药品生产许可证。截至2023年年报，歌礼制药-B营业总收入5659.6万元、净利润-1.45亿元。8月7日，预计2024年中报业绩预减，归属股东应占溢利约-1.323亿人民币至-1.273亿人民币，同比下降666.87%至696.99%。8月30日，歌礼制药-B将披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/08135942168984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","BK1574","BK1161","01672","BK1515","01477"],"gpt_icon":0},{"id":"2457353064","title":"歌礼制药－Ｂ(01672)股价下跌9%，现价港币$0.91","url":"https://stock-news.laohu8.com/highlight/detail?id=2457353064","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457353064?lang=zh_cn&edition=full","pubTime":"2024-08-08 13:58","pubTimestamp":1723096680,"startTime":"0","endTime":"0","summary":"[下跌股]歌礼制药－Ｂ(01672) 股价在下午01:58比前收市价下跌9%，现股价为港币$0.91。至目前为止，今日最高价为$0.96，而最低价为$0.91。总成交量为79.2万股，总成交金额为港币$74.206万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2408081956/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","01672","BK1574","01477","BK1191","BK1161"],"gpt_icon":0},{"id":"2457685338","title":"【盈警股】歌礼制药-B(01672)跌5% 料中期净亏损至多1.3亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2457685338","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457685338?lang=zh_cn&edition=full","pubTime":"2024-08-08 10:36","pubTimestamp":1723084611,"startTime":"0","endTime":"0","summary":"金吾财讯 | 歌礼制药-B(01672)早盘受压，截至发稿，跌5%，报0.95港元。消息面上，公司公布，预期截至6月30日止中期占净亏损介乎1.27亿至1.3亿元(人民币．下同)，比去年同期净亏损1660万元大幅增加。净亏损增加主因内地新冠肺炎疫情得到有效控制，令市场对利托那韦产品的需求收缩，因此上半年并无录得利托那韦产品销售收入，而且研发成本较增加，因在研候选药物研发方面不断取得进展。","market":"nz","thumbnail":"https://static.szfiu.com/news/20200915/NDRmNzljZmMyYzdlZTk1NTA3MWQyNTAwMjM0Njg4MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NDRmNzljZmMyYzdlZTk1NTA3MWQyNTAwMjM0Njg4MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1941897","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","01477","BK1515","BK1161","BK1191","BK1574"],"gpt_icon":0},{"id":"2457388216","title":"【湾区早参】香港7月外汇储备资产增加30亿美元；7月住宅租售比率录约77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457388216","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457388216?lang=zh_cn&edition=full","pubTime":"2024-08-08 08:30","pubTimestamp":1723077029,"startTime":"0","endTime":"0","summary":"连同未交收外汇合约在内，香港于7月底的外汇储备资产为4187亿美元，较6月底的4160亿美元，增加27亿美元。以美联物业促成的住宅租赁业务及买卖个案作计算，美联住宅租售比率7月录约77%，较6月约74%按月增加约3个百分点，创9个月新高。","market":"nz","thumbnail":"https://static.szfiu.com/news/20200915/ZTMxNjQ3ZDUxMTYwMDE1MDQzMDE2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/ZTMxNjQ3ZDUxMTYwMDE1MDQzMDE2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1941876","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APE","BK1161","BK1522","BK1500","IE00BWDBJ730.SGD","BK4108","BK1515","BK1521","LU2328871848.SGD","BK1574","LU1969619763.USD","BK1549","LU0307460666.USD","LU0449509016.USD","BK1237","SG9999004220.SGD","BK1506","06911","LU0054450605.USD","02039","LU2242644610.SGD","01672","IE00B19Z5X02.USD","06698","LU0214875030.USD","03899","BK1109","BK1583","LU0449515922.USD","BK1588","BK1183","01888","LU0588546209.SGD","BK1507","02121","00220","06160","BK1170","BK1128","IE00BQJZWZ67.USD"],"gpt_icon":0},{"id":"2457824032","title":"《盈警》歌礼制药(01672.HK)亏损大增  上半年最少蚀1.27亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2457824032","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457824032?lang=zh_cn&edition=full","pubTime":"2024-08-08 00:55","pubTimestamp":1723049700,"startTime":"0","endTime":"0","summary":"歌礼制药－Ｂ(01672.HK) 发盈警，预计6月止六个月亏损介乎1.27亿至1.32亿人民币，相较上年同期录得1,660万人民币。亏损大幅增加主要因内地的新冠肺炎疫情得到有效控制，令市场对利托那韦产品的需求收缩，公司期间并无录得利托那韦产品销售收入，而且研发成本有所增加。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/03/25末期业绩无派息2023/08/22中期业绩无派息2023/03/20末期业绩无派息 2022/08/22中期业绩无派息 AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200428112816451_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200428112816451_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1369763/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","01672","01477","BK1515","BK1574","BK1161"],"gpt_icon":0},{"id":"2457611844","title":"歌礼制药-B发盈警 预计中期净亏损大幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2457611844","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457611844?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:34","pubTimestamp":1723037686,"startTime":"0","endTime":"0","summary":"歌礼制药-b(01672)发布公告，集团预期截至2024年6月30日止六个月取得公司权益拥有人应占净亏损介于人民币1.273亿元至1.323亿元，较截至2023年6月30日止六个月的净亏损大幅增加(截至2023年6月30日止六个月：约人民币1660万元)。董事会认为公司权益拥有人应占净亏损增加主要是由于中国内地的新冠肺炎疫情得到有效控制，令市场对利托那韦产品的需求收缩，因此公司于2024年上半年并无取得利托那韦产品销售收入，而且研发成本较截至2023年6月30日止六个月有所增加，原因为集团在其在研候选药物研发方面不断取得进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072145429f177b35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072145429f177b35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","BK1574","BK1191","BK1594","01477","BK1515","BK1135","03323","BK1563","BK1161","01672","BK1503"],"gpt_icon":0},{"id":"2457418848","title":"歌礼制药-B(01672)发盈警 预计中期净亏损大幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2457418848","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457418848?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:32","pubTimestamp":1723037542,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，集团预期截至2024年6月30日止六个月取得公司权益拥有人应占净亏损介于人民币1.273亿元至1.323亿元，较截至2023年6月30日止六个月的净亏损大幅增加。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1161307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","01477","01672","BK1191","BK1574","BK1515"],"gpt_icon":0},{"id":"2457495678","title":"歌礼制药-B(01672.HK)盈警：预期中期净亏损大幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2457495678","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457495678?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:25","pubTimestamp":1723037110,"startTime":"0","endTime":"0","summary":"格隆汇8月7日丨歌礼制药-B(01672.HK)公告，集团预期截至2024年6月30日止六个月录得公司权益拥有人应占净亏损人民币127.3百万元至人民币132.3百万元，较上年同期的净亏损大幅增加（上年同期：约人民币16.6百万元）。董事会认为公司权益拥有人应占净亏损增加主要是由于中国内地的新冠肺炎疫情得到有效控制，令市场对利托那韦产品的需求收缩，因此公司于2024年上半年并无录得利托那韦产品销售收入，而且研发成本较上年同期有所增加，原因为集团在其在研候选药物研发方面不断取得进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072125149585edd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072125149585edd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","01477","BK1191","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"2457313948","title":"歌礼制药-B盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457313948","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457313948?lang=zh_cn&edition=full","pubTime":"2024-08-07 09:42","pubTimestamp":1722994958,"startTime":"0","endTime":"0","summary":"2024年08月07日早盘09时42分，歌礼制药-B股票出现异动，股价快速上涨5.10%。截至发稿，该股报1.030港元/股，成交量17.2万股，换手率0.02%，振幅7.14%。歌礼制药-B股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，再鼎医药、歌礼制药-B、云康集团涨幅较大，振幅较大的相关个股有来凯医药-B、歌礼制药-B、方达控股，振幅分别为9.92%、7.14%、6.17%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080709423896824848&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080709423896824848&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1563","BK1594","03323","BK1135","BK1574","01477","BK1589","BK1515","BK1191","BK1503","01672","BK1161"],"gpt_icon":0},{"id":"2457211797","title":"歌礼制药-B盘中异动 下午盘大幅下跌5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457211797","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457211797?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:37","pubTimestamp":1722836269,"startTime":"0","endTime":"0","summary":"2024年08月05日下午盘13时37分，歌礼制药-B股票出现异动，股价快速跳水5.66%。截至发稿，该股报1.000港元/股，成交量51.8万股，换手率0.05%，振幅4.72%。歌礼制药-B股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，嘉和生物-B、泰格医药、乐普生物-B涨幅较大，振幅较大的相关个股有乐普生物-B、方达控股、宜明昂科-B，振幅分别为19.00%、17.28%、16.35%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805133749aefd30bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805133749aefd30bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03323","BK1503","BK1563","BK1589","BK1135","BK1574","BK1594","01672","BK1161","BK1515","01477","BK1191"],"gpt_icon":0},{"id":"2455920924","title":"歌礼制药-B(01672)下跌10.66%，报1.09元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455920924","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455920924?lang=zh_cn&edition=full","pubTime":"2024-07-31 13:13","pubTimestamp":1722402830,"startTime":"0","endTime":"0","summary":"7月31日，歌礼制药-B(01672)盘中下跌10.66%，截至13:13，报1.09元/股，成交180.55万元。歌礼制药有限公司是一家创新研发驱动型生物科技公司，主要从事病毒性疾病、非酒精性脂肪性肝炎和肿瘤等三大医疗领域的新药研发、生产和商业化。该公司在浙江绍兴滨海新城拥有约17,000平方米的生产基地，设计年产能为1.3亿片，拥有多款在研药物并已取得药品生产许可证。截至2023年年报，歌礼制药-B营业总收入5659.6万元、净利润-1.45亿元。7月30日，公司以每股1.21-1.22港元回购72.5万股,回购金额88.42万港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/31131341923794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1515","01477","BK1574","01672","BK1191"],"gpt_icon":0},{"id":"2455191943","title":"歌礼制药-B盘中异动 股价大跌5.74%报1.150港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455191943","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455191943?lang=zh_cn&edition=full","pubTime":"2024-07-31 09:34","pubTimestamp":1722389669,"startTime":"0","endTime":"0","summary":"2024年07月31日早盘09时34分，歌礼制药-B股票出现异动，股价急速下跌5.74%。截至发稿，该股报1.150港元/股，成交量18.2万股，换手率0.02%，振幅4.92%。资金方面，该股资金流入4.163万港元，流出15.717万港元。歌礼制药-B股票所在的生物技术行业中，整体跌幅为0.06%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731093429af94f377&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731093429af94f377&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1135","BK1191","03323","BK1161","BK1589","BK1563","BK1574","BK1503","01672","BK1594","01477"],"gpt_icon":0},{"id":"2455437209","title":"歌礼制药－Ｂ(01672)股价下跌5.738%，现价港币$1.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2455437209","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455437209?lang=zh_cn&edition=full","pubTime":"2024-07-31 09:34","pubTimestamp":1722389640,"startTime":"0","endTime":"0","summary":"[下跌股]歌礼制药－Ｂ(01672) 股价在上午09:34比前收市价下跌5.738%，现股价为港币$1.15。至目前为止，今日最高价为$1.23，而最低价为$1.15。总成交量为18.3万股，总成交金额为港币$21.639万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD24073158/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01672","01477","BK1191","BK1161","BK1574","BK1515"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascletis.com","stockEarnings":[{"period":"1week","weight":-0.0602},{"period":"1month","weight":-0.3158},{"period":"3month","weight":-0.381},{"period":"6month","weight":-0.5714},{"period":"1year","weight":-0.6139},{"period":"ytd","weight":-0.4658}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.0174},{"period":"3month","weight":-0.0536},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0329},{"period":"ytd","weight":0.0331}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"歌礼制药有限公司是一家主要从事生物制品研发的中国公司。该公司主要专注于抗病毒、癌症及脂肪肝疾 病三大治疗领域。该公司的主要产品包括抗丙型肝炎病毒（HCV）、人类免疫缺陷病毒（HIV）及乙型肝炎（HBV）药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.102992},{"month":2,"riseRate":0.666667,"avgChangeRate":0.004802},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.105976},{"month":4,"riseRate":0.5,"avgChangeRate":-0.033468},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.025765},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.058787},{"month":7,"riseRate":0.5,"avgChangeRate":0.006985},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.100623},{"month":9,"riseRate":0,"avgChangeRate":-0.108951},{"month":10,"riseRate":0.5,"avgChangeRate":-0.070866},{"month":11,"riseRate":0.833333,"avgChangeRate":0.149725},{"month":12,"riseRate":0.5,"avgChangeRate":-0.003643}],"exchange":"SEHK","name":"歌礼制药-B","nameEN":"ASCLETIS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"歌礼制药-B,01672,歌礼制药-B股票,歌礼制药-B股票老虎,歌礼制药-B股票老虎国际,歌礼制药-B行情,歌礼制药-B股票行情,歌礼制药-B股价,歌礼制药-B股市,歌礼制药-B股票价格,歌礼制药-B股票交易,歌礼制药-B股票购买,歌礼制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}